about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
12.60
0.30
(2.44%)
122.6K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for GlycoMimetics Inc is on 08 Aug 2025 for the purpose of GlycoMimetics Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..